Clip Placement Following Colonic Endoscopic Mucosal Resection (EMR)

NCT03309683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2023-03-30

No results posted yet for this study

Summary

Study design: A national, multi-center, patient-blinded, randomized clinical trial.

Study population: Patients undergoing EMR with a moderate to severe risk (right sided colon, ≥2cm) of developing Delayed Bleeding (DB).

Intervention: PC will be compared to standard care (no PC).

Main study endpoints: Primary endpoint is the incidence of DB. Secondary endpoints are cost-effectiveness, quality of life and (severe) adverse events related to PC, adenoma recurrence and risk factors for DB.

Conditions

Interventions

DEVICE

Olympus Quick Clip Pro - Single Use Repositionable Clips

A hemoclip will be placed after every 0,5-1,0 cm of the resected area to proximate wound edges.

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • Maxima Medical Center

    collaborator OTHER
  • Jeroen Bosch Ziekenhuis

    collaborator OTHER
  • Bernhoven Hospital

    collaborator OTHER
  • Isala

    collaborator OTHER
  • Canisius-Wilhelmina Hospital

    collaborator OTHER
  • Maasstad Hospital

    collaborator OTHER
  • Noordwest Ziekenhuisgroep

    collaborator OTHER
  • Meander Medisch Centrum

    collaborator OTHER
  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER
  • Elisabeth-TweeSteden Ziekenhuis

    collaborator OTHER
  • St Jansdal Hospital

    collaborator OTHER
  • Leiden University Medical Center

    collaborator OTHER
  • Dutch Digestive Diseases Foundation

    collaborator OTHER
  • Franciscus Gasthuis

    collaborator OTHER
  • Bravis Hospital

    collaborator OTHER
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Erwin JM Van Geenen, dr · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-05
Primary Completion
2022-08-19
Completion
2023-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03309683 on ClinicalTrials.gov